Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Depreciation and Depletion: 2022-2025

Historic Depreciation and Depletion for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to $50,204.

  • InMed Pharmaceuticals' Depreciation and Depletion rose 124.37% to $12,206 in Q2 2025 from the same period last year, while for Jun 2025 it was $50,204, marking a year-over-year increase of 5.16%. This contributed to the annual value of $50,204 for FY2025, which is 5.16% up from last year.
  • InMed Pharmaceuticals' Depreciation and Depletion amounted to $50,204 in FY2025, which was up 5.16% from $47,742 recorded in FY2024.
  • InMed Pharmaceuticals' Depreciation and Depletion's 5-year high stood at $50,204 during FY2025, with a 5-year trough of $26,426 in FY2022.
  • Over the past 3 years, InMed Pharmaceuticals' median Depreciation and Depletion value was $47,742 (recorded in 2024), while the average stood at $45,853.
  • Data for InMed Pharmaceuticals' Depreciation and Depletion shows a peak YoY surged of 49.90% (in 2023) over the last 5 years.
  • Over the past 4 years, InMed Pharmaceuticals' Depreciation and Depletion (Yearly) stood at $26,426 in 2022, then skyrocketed by 49.90% to $39,613 in 2023, then rose by 20.52% to $47,742 in 2024, then climbed by 5.16% to $50,204 in 2025.